Variant report
Variant | esv3432379 |
---|---|
Chromosome Location | chr20:12770696-12771255 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535421580 | chr20:12770718-12770719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150726174 | chr20:12770725-12770726 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575379618 | chr20:12770736-12770737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142419520 | chr20:12770770-12770771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7361405 | chr20:12770782-12770783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557227068 | chr20:12770787-12770788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577378999 | chr20:12770790-12770791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs620789 | chr20:12770811-12770812 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs559973700 | chr20:12770834-12770835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573041685 | chr20:12770851-12770852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117239023 | chr20:12770856-12770857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541787488 | chr20:12770866-12770867 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs474250 | chr20:12770888-12770889 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs530863677 | chr20:12770910-12770911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565938329 | chr20:12770925-12770926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145971895 | chr20:12771049-12771050 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117347203 | chr20:12771067-12771068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139652772 | chr20:12771074-12771075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546507731 | chr20:12771084-12771085 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566760658 | chr20:12771105-12771106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535767415 | chr20:12771111-12771112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76273107 | chr20:12771134-12771135 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189083605 | chr20:12771200-12771201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537504205 | chr20:12771247-12771248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557825608 | chr20:12771250-12771251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376865529 | chr20:12771251-12771252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:12769200-12770800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr20:12770200-12771000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr20:12770200-12771200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr20:12770200-12771200 | Weak transcription | Fetal Kidney | kidney |
5 | chr20:12770200-12771800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr20:12770400-12770800 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr20:12770400-12771000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr20:12770600-12771000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr20:12770800-12778800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr20:12771000-12777800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr20:12771200-12772000 | Enhancers | Fetal Kidney | kidney |